Skip to main content
Top
Published in:

26-07-2023 | Human Immunodeficiency Virus | Substantive Review

Examining Concordance Between Self-Report and Biomedical HIV Viral Load Data: A Scoping Review

Authors: Molly Dorshimer, Sabina Hirshfield, Joseph Mayer, Angela A. Aidala

Published in: AIDS and Behavior | Issue 1/2024

Login to get access

Abstract

Assessment of HIV viral load based on laboratory results is the gold standard in HIV care and research. However, blood assay or accessing medical records is not always possible due to research or service contexts and constraints. Self-report of viral load test results expands data resources, is a convenient method of collecting data in both research and service settings, and is useful for HIV surveillance. The purpose of this scoping review was to identify existing literature on the validity of self-reported viral load data compared to blood assay or medical record review. We found that the existing literature is limited, with varied data collection methods, self-report measures, and study designs, as well as predictors of accuracy. Concordance between self-reported viral load and biomedical data varied across studies but appeared to be more consistent among samples recruited from clinical populations that reported engagement in HIV care. While it is difficult to draw definitive conclusions about the validity of self-reported viral load across existing studies, there is a need for a standardized measure and method of collection that can be utilized across diverse populations living with HIV.
Appendix
Available only for authorised users
Literature
11.
go back to reference Mustanski B, Ryan DT, Remble TA, D’Aquila RT, Newcomb ME, Morgan E. Discordance of self-report and laboratory measures of HIV viral load among young men who have sex with men and transgender women in Chicago: Implications for Epidemiology, Care, and Prevention. AIDS Behav. 2018;22:2360–7. https://doi.org/10.1007/s10461-018-2112-7.CrossRef Mustanski B, Ryan DT, Remble TA, D’Aquila RT, Newcomb ME, Morgan E. Discordance of self-report and laboratory measures of HIV viral load among young men who have sex with men and transgender women in Chicago: Implications for Epidemiology, Care, and Prevention. AIDS Behav. 2018;22:2360–7. https://​doi.​org/​10.​1007/​s10461-018-2112-7.CrossRef
12.
14.
go back to reference HIV Epidemiology Program. HIV Surveillance Annual Report. (2020). New York City Department of Health and Mental Hygiene: New York, NY. December 2021. HIV Epidemiology Program. HIV Surveillance Annual Report. (2020). New York City Department of Health and Mental Hygiene: New York, NY. December 2021.
16.
go back to reference Kinsler JJ, Cunningham WE, Mohanty S, Wong MD. Are medical records a more reliable and valid source of CD4 count, viral load, and outpatient visit data than self-reports? A comparison with electronic medical records as the gold standard. Health Serv Outcomes Res Method. 2008;8:187–200. https://doi.org/10.1007/s10742-008-0036-9.CrossRef Kinsler JJ, Cunningham WE, Mohanty S, Wong MD. Are medical records a more reliable and valid source of CD4 count, viral load, and outpatient visit data than self-reports? A comparison with electronic medical records as the gold standard. Health Serv Outcomes Res Method. 2008;8:187–200. https://​doi.​org/​10.​1007/​s10742-008-0036-9.CrossRef
17.
18.
go back to reference Mariller MM, Abramson D, Sobieszcyk M. The validity of self- reported clinical markers and medication regimens: A pilot study. NYC CHAIN Report; 2004. Mariller MM, Abramson D, Sobieszcyk M. The validity of self- reported clinical markers and medication regimens: A pilot study. NYC CHAIN Report; 2004.
19.
go back to reference Messeri P, McAllister-Hollod L, Irvine M. Validating self-reported HIV test results using surveillance registry data. NYC CHAIN Report; 2012. Messeri P, McAllister-Hollod L, Irvine M. Validating self-reported HIV test results using surveillance registry data. NYC CHAIN Report; 2012.
21.
go back to reference Institute of Medicine (IOM). Monitoring HIV care in the United States: Indicators and data systems. Washington, DC: The National Academies Press; 2012. Institute of Medicine (IOM). Monitoring HIV care in the United States: Indicators and data systems. Washington, DC: The National Academies Press; 2012.
30.
go back to reference Muessig KE, Golinkoff JM, Hightow-Weidman LB, et al. Increasing HIV testing and viral suppression via stigma reduction in a social networking mobile health intervention among Black and Latinx young men and transgender women who have sex with men (HealthMpowerment): Protocol for a randomized controlled trial. JMIR Res Protoc. 2020;9(12):e24043. https://doi.org/10.2196/24043.CrossRefPubMedPubMedCentral Muessig KE, Golinkoff JM, Hightow-Weidman LB, et al. Increasing HIV testing and viral suppression via stigma reduction in a social networking mobile health intervention among Black and Latinx young men and transgender women who have sex with men (HealthMpowerment): Protocol for a randomized controlled trial. JMIR Res Protoc. 2020;9(12):e24043. https://​doi.​org/​10.​2196/​24043.CrossRefPubMedPubMedCentral
Metadata
Title
Examining Concordance Between Self-Report and Biomedical HIV Viral Load Data: A Scoping Review
Authors
Molly Dorshimer
Sabina Hirshfield
Joseph Mayer
Angela A. Aidala
Publication date
26-07-2023
Publisher
Springer US
Published in
AIDS and Behavior / Issue 1/2024
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-023-04136-7

Other articles of this Issue 1/2024

AIDS and Behavior 1/2024 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Webinar | 06-02-2024 | 20:00 (CET)

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Sponsored by: Viatris

Developed by: Springer Healthcare
Live Webinar | 01-10-2024 | 12:30 (CEST)

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

Live: Tuesday 1st October 2024, 12:30-14:00 (CEST)

In this live webinar, Professor Martin Dreyling and an esteemed, international panel of CAR-T experts will discuss the very latest data on the safety, efficacy and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL, as presented at ASH 2023, EU CAR-T 2024, and EHA 2024. 

Please note, this webinar is not intended for healthcare professionals based in the US and UK.

Sponsored by: Novartis Pharma AG

Chaired by: Prof. Martin Dreyling
Developed by: Springer Healthcare